FDA Compliance. The Company and its Subsidiaries, and the manufacture, marketing and sales of the Company's products, complies with any and all applicable requirements of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. ss.301, et seq., any rules and regulations of the Food and Drug Administration promugulated thereunder, and any similar laws outside of the United States to which the company is subject, except where such noncompliance would not have a Material Adverse Effect.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Aphton Corp), Securities Purchase Agreement (Stemcells Inc), Securities Purchase Agreement (Stemcells Inc)
FDA Compliance. The Company and its Subsidiaries, and the manufacture, marketing and sales of the Company's products, complies its products comply with any and all applicable requirements of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. ss.301§ 301, et seq., any rules and regulations of the Food and Drug Administration promugulated promulgated thereunder, and any similar laws outside of the United States to which the company Company is subject, except where such noncompliance would not not, individually or in the aggregate, have a Material Adverse Effectmaterial adverse effect on the Company.
Appears in 2 contracts
Samples: Common Stock Purchase Agreement (Medwave Inc), Common Stock Purchase Agreement (Medwave Inc)
FDA Compliance. The Company and its SubsidiariesCompany, and the manufacture, marketing and sales of the Company's its products, complies comply with any and all applicable requirements of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. ss.301§ 301, et seq., any rules and regulations of the Food and Drug Administration promugulated promulgated thereunder, and any similar laws outside of the United States to which the company Company is subject, except where such noncompliance would not not, individually or in the aggregate, have a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Clarient, Inc), Securities Purchase Agreement (Clarient, Inc)
FDA Compliance. The Company and its Subsidiaries, and the manufacture, marketing and sales of the Company's products, complies with any and all applicable requirements of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. ss.301Section 301, et seq., any rules and regulations of the Food and Drug Administration promugulated thereunder, and any similar laws outside of the United States to which the company is subject, except where such noncompliance would not not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (Nastech Pharmaceutical Co Inc)
FDA Compliance. The Company and its SubsidiariesCompany, and the manufacture, marketing and sales of the Company's its products, complies comply with any and all applicable requirements of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. ss.301Section 301, et seq., any rules and regulations of the Food and Drug Administration promugulated promulgated thereunder, and any similar laws outside of the United States to which the company Company is subject, except where such noncompliance would not not, individually or in the aggregate, have a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (Chromavision Medical Systems Inc)
FDA Compliance. The Company and its Subsidiaries, and the manufacture, marketing and sales of the Company's ’s products, complies with any and all applicable requirements of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. ss.301, et seq., any rules and regulations of the Food and Drug Administration promugulated promulgated thereunder, and any similar laws outside of the United States to which the company is subject, except where such noncompliance would not have a Material Adverse Effect.
Appears in 1 contract
Samples: Exchange Agreement (Aphton Corp)
FDA Compliance. The Company and each of its Subsidiaries, and the manufacture, marketing and sales of the Company's their products, complies comply with any and all applicable requirements of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. ss.301Section 301, et seq., any rules and regulations of the Food and Drug Administration promugulated promulgated thereunder, and any similar laws outside of the United States States, including the applicable PRC food and drug administration Laws to which the company Company or any of its Subsidiaries is subject, except where such noncompliance would not not, individually or in the aggregate, have a Material Adverse Effect.
Appears in 1 contract
Samples: Convertible Redeemable Preferred Share and Warrant Purchase Agreement (Lotus Pharmaceuticals, Inc.)
FDA Compliance. The Company and its Subsidiaries, and the manufacture, marketing and sales of the Company's products, complies with any and all applicable requirements of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. ss.301Section 301, et seq., any rules and regulations of the Food and Drug Administration promugulated thereunder, and any similar laws outside of the United States to which the company is subject, except where such noncompliance would not have a Material Adverse Effect.
Appears in 1 contract
